N-ACETYL CYSTEINE IN THE ADJUNCTIVE TREATMENT OF OBSESSIVE COMPUSLIVE DISORDER: A 16-WEEK, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY
Grant number: 1104460 | Funding period: 2016 - 2021
The aim of our proposed study, is investigate the efficacy and safety of adjunctive N-acetyl cysteine (NAC), an amino-acid based agent in the treatment of 200 adults with diagnosed OCD. The study proposed is a 16-week, doubled-blind, randomised, placebo-controlled trial. If NAC is found to be effective in this study, the treatment of OCD will be strongly influenced, resulting in global impact for the potential alleviation of suffering for those with the mental disorder.